Cargando…
The Influence of SARS-CoV-2 Infection on Acute Myocardial Infarction Outcomes
Background: This multicenter retrospective study with a control group was designed to assess the influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the outcomes of patients with myocardial infarction (MI). Methods: A total of 129 patients with COVID-19 who were tr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532337/ https://www.ncbi.nlm.nih.gov/pubmed/37762840 http://dx.doi.org/10.3390/jcm12185899 |
_version_ | 1785111936247005184 |
---|---|
author | Hrycek, Eugeniusz Walawska-Hrycek, Anna Hamankiewicz, Maciej Milewski, Krzysztof Nowakowski, Przemysław Buszman, Piotr Żurakowski, Aleksander |
author_facet | Hrycek, Eugeniusz Walawska-Hrycek, Anna Hamankiewicz, Maciej Milewski, Krzysztof Nowakowski, Przemysław Buszman, Piotr Żurakowski, Aleksander |
author_sort | Hrycek, Eugeniusz |
collection | PubMed |
description | Background: This multicenter retrospective study with a control group was designed to assess the influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the outcomes of patients with myocardial infarction (MI). Methods: A total of 129 patients with COVID-19 who were treated for MI were included in this study. The control group comprised 129 comparable patients without SARS-CoV-2 infection. The in-hospital, out-of-hospital, and overall mortality were analyzed. Results: A total of thirty-one (24%) patients died in the study group, and two (1.6%) patients died in the control group (OR = 20.09; CI: 4.69–85.97; p < 0.001). Similar results were observed in all analyzed patient subgroups. Multivariable Cox regression analysis confirmed the significant influence of SARS-CoV-2 infection on in-hospital outcomes (HR: 8.48459; CI: 1.982–36.320; p = 0.004). Subanalysis of the groups with COVID-19 plus ST-elevation MI (STEMI) or non-ST-elevation MI (NSTEMI) revealed comparable mortality rates: 14 (21.12%) patients in the NSTEMI group and 17 (26.98%) patients in the STEMI subgroup died (OR: 1.3; CI: 0.56–3.37; p = 0.45). During out-of-hospital observation, no differences in mortality were observed (OR: 0.77; CI: 0.11–4.07; p = 0.73). Conclusions: SARS-CoV-2 infection affects the in-hospital outcomes of patients with both MI and COVID-19, regardless of MI type (STEMI vs. NSTEMI). |
format | Online Article Text |
id | pubmed-10532337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105323372023-09-28 The Influence of SARS-CoV-2 Infection on Acute Myocardial Infarction Outcomes Hrycek, Eugeniusz Walawska-Hrycek, Anna Hamankiewicz, Maciej Milewski, Krzysztof Nowakowski, Przemysław Buszman, Piotr Żurakowski, Aleksander J Clin Med Article Background: This multicenter retrospective study with a control group was designed to assess the influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the outcomes of patients with myocardial infarction (MI). Methods: A total of 129 patients with COVID-19 who were treated for MI were included in this study. The control group comprised 129 comparable patients without SARS-CoV-2 infection. The in-hospital, out-of-hospital, and overall mortality were analyzed. Results: A total of thirty-one (24%) patients died in the study group, and two (1.6%) patients died in the control group (OR = 20.09; CI: 4.69–85.97; p < 0.001). Similar results were observed in all analyzed patient subgroups. Multivariable Cox regression analysis confirmed the significant influence of SARS-CoV-2 infection on in-hospital outcomes (HR: 8.48459; CI: 1.982–36.320; p = 0.004). Subanalysis of the groups with COVID-19 plus ST-elevation MI (STEMI) or non-ST-elevation MI (NSTEMI) revealed comparable mortality rates: 14 (21.12%) patients in the NSTEMI group and 17 (26.98%) patients in the STEMI subgroup died (OR: 1.3; CI: 0.56–3.37; p = 0.45). During out-of-hospital observation, no differences in mortality were observed (OR: 0.77; CI: 0.11–4.07; p = 0.73). Conclusions: SARS-CoV-2 infection affects the in-hospital outcomes of patients with both MI and COVID-19, regardless of MI type (STEMI vs. NSTEMI). MDPI 2023-09-11 /pmc/articles/PMC10532337/ /pubmed/37762840 http://dx.doi.org/10.3390/jcm12185899 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hrycek, Eugeniusz Walawska-Hrycek, Anna Hamankiewicz, Maciej Milewski, Krzysztof Nowakowski, Przemysław Buszman, Piotr Żurakowski, Aleksander The Influence of SARS-CoV-2 Infection on Acute Myocardial Infarction Outcomes |
title | The Influence of SARS-CoV-2 Infection on Acute Myocardial Infarction Outcomes |
title_full | The Influence of SARS-CoV-2 Infection on Acute Myocardial Infarction Outcomes |
title_fullStr | The Influence of SARS-CoV-2 Infection on Acute Myocardial Infarction Outcomes |
title_full_unstemmed | The Influence of SARS-CoV-2 Infection on Acute Myocardial Infarction Outcomes |
title_short | The Influence of SARS-CoV-2 Infection on Acute Myocardial Infarction Outcomes |
title_sort | influence of sars-cov-2 infection on acute myocardial infarction outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532337/ https://www.ncbi.nlm.nih.gov/pubmed/37762840 http://dx.doi.org/10.3390/jcm12185899 |
work_keys_str_mv | AT hrycekeugeniusz theinfluenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT walawskahrycekanna theinfluenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT hamankiewiczmaciej theinfluenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT milewskikrzysztof theinfluenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT nowakowskiprzemysław theinfluenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT buszmanpiotr theinfluenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT zurakowskialeksander theinfluenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT hrycekeugeniusz influenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT walawskahrycekanna influenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT hamankiewiczmaciej influenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT milewskikrzysztof influenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT nowakowskiprzemysław influenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT buszmanpiotr influenceofsarscov2infectiononacutemyocardialinfarctionoutcomes AT zurakowskialeksander influenceofsarscov2infectiononacutemyocardialinfarctionoutcomes |